Results 101 to 110 of about 1,097,866 (354)

Noise in multiple sclerosis: unwanted and necessary [PDF]

, 2014
As our knowledge about the etiology of multiple sclerosis (MS) increases, deterministic paradigms appear insufficient to describe the pathogenesis of the disease, and the impression is that stochastic phenomena (i.e.
BORDI, Isabella, CRISANTI, Andrea, GRASSI, Francesca, Renato Umeton, RISTORI, GIOVANNI, SALVETTI, Marco, SUTERA, Alfonso, Vito A. G. Ricigliano   +7 more
core   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Web-based physiotherapy for people affected by multiple sclerosis: a single blind, randomized controlled feasibility study [PDF]

, 2018
Objective: To examine the feasibility of a trial to evaluate web-based physiotherapy compared to a standard home exercise programme in people with multiple sclerosis. Design: Multi-centre, randomized controlled, feasibility study.
Alex McConnachie, Belinda Weller, Berg K, Brazier J, Brennan DM, Cohen J., Curtis L, Elaine H Coulter, Frevel D, Heather Murray, Jennifer Freeman, Khan F, Linda Renfrew, Lorna Paul, Olivia Wu, Paul Mattison, Robert Heggie   +16 more
core   +3 more sources

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela, Madison Reeves, Karen Jansen‐West, Judith Dunmore, Yuping Song, Audrey Strongosky, Sunil Gandhi, Gilana Pikover, Matt Blurton‐Jones, Robert C. Spitale, Erik H. Middlebrooks, Leonard Petrucelli, Mercedes Prudencio, Zbigniew K. Wszolek   +13 more
wiley   +1 more source

The Unyielding Enigma

Journal of Indian Academy of Oral Medicine and Radiology
Scleroderma, an autoimmune connective tissue disorder marked by profound fibrosis in visceral organs, skin, and blood vessels, exhibits oral manifestations typically initiating with tongue rigidity and facial skin alterations. It presents with a plethora
Hima John, Jiss Mary, Jeslin James, S Devu   +3 more
doaj   +1 more source

Psychiatric manifestations of multiple sclerosis and acute disseminated encephalomyelitis [PDF]

, 2006
It is unusual for acute disseminated encephalomyelitis and multiple sclerosis to present as purely psychiatric disorders. We report five patients with such demyelinating diseases and symptoms of psychosis, depression or anxiety.
Brinar, Marko, Brinar, Vesna V., Habek, Mario, Poser, Charles M.   +3 more
core   +1 more source

The Case of a 28‐Year‐Old Woman With Medically Refractory Focal Epilepsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT We present the case of a 28‐year‐old right‐handed woman with medically refractory focal epilepsy. Her seizure semiology and electroencephalography (EEG) indicated a seizure onset zone in the right central‐parietal area. However, both MRI and PET scans were unremarkable, showing no focal lesions or areas of altered metabolism.
Rishi Sharma, Ilo Leppik, Thomas Henry, Thaddeus Walczak, Sima Patel, Robert McGovern   +5 more
wiley   +1 more source

Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis

Journal of Research in Medical Sciences, 2013
Background: One of the frequent symptoms of Multiple Sclerosis (MS) is tremor which can severely cause disability. Treatment of tremor in MS patients is still very challenging to manage. In this study, we sought to determine the efficacy of Levetiracetam
Ahmad Chitsaz, Noushin Mehrbod, Masoud Etemadifar, Mohamadreza Najafi   +3 more
doaj  

Functioning and disability in multiple sclerosis from the patient perspective [PDF]

, 2011
Multiple sclerosis (MS) has a great impact on functioning and disability. The perspective of those who experience the health problem has to be taken into account to obtain an in-depth understanding of functioning and disability.
Alarcos Cieza, Birgit Basedow-Rajwich, Cieza A, Denzin N, Folstein M, Jürg Kesselring, Karlsson G, Kvale S, Michaela Coenen, Nicolaus König, Patton MQ, Simioni S, Stuifbergen A, World Health Organisation   +13 more
core   +1 more source

Multiple Sclerosis and the Risk of Cardiovascular Diseases: A Mendelian Randomization Study [PDF]

, 2022
Fangkun Yang, Teng Hu, Kewan He, Jiajun Ying, Hanbin Cui   +4 more
openalex   +1 more source